Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma

NCT01327521 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Accrual below target levels

Conditions

Carcinoma, Hepatocellular

Interventions

DEVICE: CyberKnife
PROCEDURE: TACE
DRUG: CT Contrast
DRUG: doxorubicin
DRUG: Epirubicin
DRUG: 5-fluorouracil
DRUG: Mitomycin C
DRUG: Gemcitabine
DRUG: Cisplatin
DEVICE: SMANCS

Sponsor

Albert Koong

Collaborators

[object Object]